Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
Explore the potential of Rejoyn™, a digital therapeutic now cleared by the FDA, which has shown to significantly reduce depressive symptoms in adults as an adjunct to traditional outpatient care, without any reported adverse events.
Psychiatry April 9th 2024
The New England Journal of Medicine
Wearable digital health technologies are setting a new standard in patient care, offering insights into daily physiological and behavioral patterns that were previously inaccessible, enabling a more nuanced approach to disease management and patient engagement.
All Specialties April 3rd 2024
The Dermatologist
In the realm of dermatology, AI and ML are not just futuristic concepts but practical tools enhancing diagnostic precision, patient care, and administrative efficiency. These technologies are reshaping how dermatologists interact with data, patients, and their own continuing education.
Dermatology March 25th 2024
Mayo Clinic
Join a confluence of experts at the Mayo Clinic Innovations in Gastroenterology and Hepatology 2024, where the latest advancements in AI, digital tools, and endoscopic technology promise to redefine patient care in gastroenterology and hepatology.
Gastroenterology March 25th 2024
First Report Managed Care
As physicians, understanding the new biomarker legislation is crucial—it not only shapes insurance coverage but also influences clinical decision-making and patient access to precision medicine, potentially leading to more cost-effective and targeted care.
All Specialties March 25th 2024
MDLinx
In a significant stride toward personalized medicine, researchers have utilized AI to unveil two distinct evotypes of prostate cancer, heralding a new era in the disease’s diagnosis and management. This pivotal discovery opens doors to tailored treatment strategies, potentially mitigating the adverse effects of over-treatment in prostate cancer.
Hematology/Oncology March 25th 2024